Exelixis (EXEL) EBIT (2010 - 2026)
Exelixis' EBIT was $248.41 million in Q2 2027, up 16.3% from $213.58 million a year earlier but down 1.2% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) EBIT (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Exelixis' EBIT was $971.51 million through Jul 3, 2026, up 38.8% year-over-year; for FY2026, it was $872.19 million, up 44.3% from FY2025.
- EBIT shows a five-year compound annual growth rate of 24.9% (FY2021 to FY2026).
- In earlier years, EBIT was $604.62 million in FY2025, $170.89 million in FY2023 (-15.2%) and $201.48 million in FY2022 (-29.7%).
- Quarterly EBIT has moved between $29.46 million (Q1 2025) and $275.87 million (Q2 2025) over five years.
- Compared with a year earlier, EBIT has increased for four straight quarters, with growth averaging 113.4% over the last six quarters.
- Per Business Quant data, EXEL's EBIT in the three quarters before Q2 2027 was $251.34 million (Q1 2027), $235.22 million (Q4 2026) and $236.54 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Exelixis | 14.53 Bn | 10.86 Bn | 608.03 Mn | 248.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 248.41 Mn |
| Apr 3, 2026 | 251.34 Mn |
| Jan 2, 2026 | 235.22 Mn |
| Oct 3, 2025 | 236.54 Mn |
| Jul 4, 2025 | 213.58 Mn |
| Apr 4, 2025 | 186.86 Mn |
| Jan 3, 2025 | 163.21 Mn |
| Sep 27, 2024 | 136.08 Mn |
| Jun 28, 2024 | 275.87 Mn |
| Mar 29, 2024 | 29.46 Mn |
| Dec 29, 2023 | 81.79 Mn |
| Sep 29, 2023 | -17.58 Mn |
| Jun 30, 2023 | 77.85 Mn |
| Mar 31, 2023 | 28.83 Mn |
| Dec 30, 2022 | -48.08 Mn |
| Sep 30, 2022 | 82.61 Mn |
| Jul 1, 2022 | 83.71 Mn |
| Apr 1, 2022 | 83.24 Mn |
| Dec 31, 2021 | 118.02 Mn |
| Oct 1, 2021 | 51.62 Mn |
API Access
Exelixis EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();